Hannah Dry

Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases.

Peter Ballard, Andrew G. Leach, Jason G Kettle, 2013, Journal of medicinal chemistry.

Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors

Dario R. Alessi, D. Alessi, S. Guichard, 2013, The Biochemical journal.